Albemarle: Capital Research reports 1.8% stake (2,111,525 sh)
Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership in Albemarle Corp. (ALB).
Rhea-AI Filing Summary
Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership in Albemarle Corp. (ALB).
CRGI beneficially owns 2,111,525 shares of Albemarle common stock, representing 1.8% of the 119,794,457 shares believed outstanding, with an event date of 09/30/2025. It has sole voting and sole dispositive power over 2,111,525 shares and no shared power. The reported position includes 4,620,404 Convertible Preferred Stocks that represent 2,111,525 common shares. CRGI certifies the securities were acquired and are held in the ordinary course and not to influence control.
Positive
- None.
Negative
- None.
FAQ
What stake in Albemarle (ALB) did Capital Research Global Investors report?
What is the event date for this Schedule 13G/A on Albemarle (ALB)?
What type of filer is CRGI in this Schedule 13G/A?
What securities are included in CRGI’s reported position in Albemarle (ALB)?
Did CRGI state an intent to influence control at Albemarle (ALB)?
AI-generated analysis. How Rhea-AI works. Not financial advice.